You searched for "treatment"
An alternative device for obstructive sleep apnoea
Continuous positive airway pressure (CPAP) is the first-line treatment for obstructive sleep apnoea (OSA), primarily due to the vast amount of short-term evidence in the medical literature it has accrued. The enduring obstacle to CPAP from becoming a treatment option...BACO International 2018: Key Speakers
Prof Aldo C Stamm, MD, MSc, PhD Anatomy of the paranasal sinuses and skull base, and breaking the paradigms in severe spontaneous epistaxis It is a true honour to participate as an invited faculty member at the upcoming BACO International...AI reshaping the landscape of head and neck cancer
With artificial intelligence set to transform almost every aspect of life, Abishek Mahajan reviews its potential to improve head and neck cancer care. Artificial intelligence (AI) has emerged as a transformative tool in healthcare. In the realm of oncology, AI...
Virtual vestibular rehabilitation (VR) is as effective as in-person VR
The effectiveness of vestibular rehabilitation (VR) for patients with several vestibular disorders is well established. Access for in-person clinic-based VR is however patchy and limited. To widen access, offering VR via virtual platforms is increasingly being adopted. The authors conducted...Aetiology, investigation and acute management of sudden sensorineural hearing loss
The cause of a single sided sensorineural hearing loss has a wide variety of aetiologies. This review, by Edwin Halliday, looks specifically at the differential diagnostic causes of a sudden sensorineural hearing loss, the relevant investigations and the management should...Hyposalivation: a review of current and future treatments
Hyposalivation remains a stubbornly difficult condition to treat, but novel therapies may not be far away. Saliva has many essential functions, including aiding digestion and swallowing, lubrication, maintaining tooth integrity and antibacterial activity. When patients experience reduced saliva production (hyposalivation),...
Patients with severe uncontrolled CRSwNP respond to biologics in the real world
Clinical trials have demonstrated that biologics are effective in treating patients with chronic rhinosinusitis with nasal polyps (CRSwNP). This multicentre (15 tertiary care centres in France) observational prospective cohort study aims to examine the effectiveness of biologics in treating CRSwNP...How will our grandchildren view COVID-19?
Alan Johnson, known to our readers as the former President of ENT UK, gives us his thoughts on the COVID pandemic, looking at it through the lens of other health crises. As I write, COVID-19 is displacing almost all other...
Omalizumab for CRSwNP: a monoclonal antibody
A prospective study from London, evaluating the response of chronic rhinosinusitis patients with nasal polyposis who were being treated with monoclonal antibody against IgE for severe allergic asthma. Thirteen patients were treated with Omalizumab, according to UK guidelines for their...
Supplementing intranasal cortical steroids with montelukast: does it help?
Intranasal steroids are widely used in the treatment of allergic rhinitis. Whether or not the addition of montelukast helps was assessed in this study. This was a single centre prospective randomised double-blind placebo-controlled trial of two groups of patients, one...
The polyp shrinker
Inflammatory markers, including T2 cells beta common (βc) cytokines IL-3, IL5 and granulocyte-macrophage colony-stimulating factor (GM-CSF), are known to play an important role in chronic rhinosinusitis with nasal polyps (CRSwNP). CSL311, a monoclonal antibody (mAb), was developed to target human...
